← Oncology Approval Tracker

FDA DECISION ·

Yervoy

ipilimumab · Bristol Myers Squibb

FDA approvalNew dosing regimenMelanoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Changes the adjuvant melanoma regimen after complete resection in the labeled population from 10 mg/kg to 3 mg/kg and shortens the IV infusion from 90 to 30 minutes.

LAMPGEN ANALYSIS

Why it matters

FDA approved a lower dose and shorter infusion in the existing adjuvant melanoma setting.

What research teams should watch

Retire obsolete order sets and check the indication-specific weight-based dose when reconciling older protocols.

PRIMARY RECORDS

Sources